Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.9 [0.86-0.95],1.32668001052761e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCGN,Secretagogin,Inverse variance weighted,5,1.09 [1.03-1.15],0.00300184872411355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIGLEC1,Sialoadhesin,Inverse variance weighted,5,1.06 [1.02-1.11],0.00411217206426528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL11,Eotaxin,Inverse variance weighted,5,1.07 [1.02-1.13],0.00478320345862903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COLEC12,Collectin-12,Inverse variance weighted,5,0.94 [0.9-0.98],0.00484648211069881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,5,0.93 [0.89-0.98],0.00508399352707576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,5,1.06 [1.02-1.1],0.00567653589229034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,5,0.94 [0.9-0.98],0.00579846851764558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,5,0.94 [0.9-0.98],0.0079594516428508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPP1,Osteopontin,Inverse variance weighted,5,0.93 [0.88-0.98],0.00833663427917025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CFD,Complement factor D,Inverse variance weighted,5,0.94 [0.9-0.99],0.00938389160270505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,5,0.95 [0.92-0.99],0.0094989850862484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPPB,Natriuretic peptides B,Inverse variance weighted,5,0.94 [0.9-0.99],0.0109881794629115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REN,Renin,Inverse variance weighted,5,1.06 [1.01-1.1],0.0116440981082204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,5,0.95 [0.91-0.99],0.0130361628790812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFNB2,Ephrin-B2,Inverse variance weighted,5,0.94 [0.9-0.99],0.0145854891948786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK11,Kallikrein-11,Inverse variance weighted,5,0.95 [0.91-0.99],0.0153031168176779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH17,Cadherin-17,Inverse variance weighted,5,1.05 [1.01-1.09],0.016927780914679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL25,C-C motif chemokine 25,Inverse variance weighted,5,1.06 [1.01-1.1],0.0181333851047945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,5,0.95 [0.91-0.99],0.0181628099036178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP1,Insulin-like growth factor-binding protein 1,Inverse variance weighted,5,0.93 [0.88-0.99],0.0205348297868617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MSMB,Beta-microseminoprotein,Inverse variance weighted,5,0.96 [0.92-0.99],0.0225369394584932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,5,1.05 [1.01-1.1],0.0239395397257381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD70,CD70 antigen,Inverse variance weighted,5,0.96 [0.93-1],0.0258296739113553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,5,1.07 [1.01-1.14],0.0265034160869207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANXA5,Annexin A5,Inverse variance weighted,5,0.95 [0.91-0.99],0.0288243582432628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,5,0.96 [0.93-1],0.0302792406804593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,5,0.96 [0.92-1],0.0324431773148381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,5,0.95 [0.91-1],0.0352366406668009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NFASC,Neurofascin,Inverse variance weighted,5,1.08 [1-1.17],0.0370609690595338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD59,CD59 glycoprotein,Inverse variance weighted,5,0.96 [0.92-1],0.0386073353000851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,5,1.09 [1-1.18],0.0393065050011209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,5,0.89 [0.79-0.99],0.0395745481432421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHRDL1,Chordin-like protein 1,Inverse variance weighted,5,0.96 [0.92-1],0.0401805181170791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,5,0.95 [0.9-1],0.0441444579013324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,5,0.96 [0.93-1],0.0458273825999737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS4,Galectin-4,Inverse variance weighted,5,1.09 [1-1.19],0.0491915274081782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,5,1.05 [1-1.09],0.0511982553864361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HEPH,Hephaestin,Inverse variance weighted,5,1.06 [1-1.13],0.0516136303036923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,0.96 [0.91-1],0.0529996408127825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,5,0.96 [0.92-1],0.0539863486207779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PALM,Paralemmin-1,Inverse variance weighted,5,0.95 [0.9-1],0.0577203988345776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,5,1.09 [1-1.18],0.057989358608078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,5,0.95 [0.89-1],0.0581642549937912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CST6,Cystatin-M,Inverse variance weighted,5,0.95 [0.9-1],0.0602824192841635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,5,1.04 [1-1.09],0.0607951312921624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,5,0.95 [0.91-1],0.0608728014409684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH1,Cadherin-1,Inverse variance weighted,5,1.04 [1-1.09],0.0622175738194998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,5,1.04 [1-1.09],0.0631701326775638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,APOA4,Apolipoprotein A-IV,Inverse variance weighted,5,1.04 [1-1.09],0.0651739509796311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,5,0.96 [0.93-1],0.0677924697936175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,5,0.96 [0.91-1],0.0683798896826105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,5,1.05 [1-1.11],0.0691251259645838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,1.04 [1-1.09],0.0701712243730626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,5,0.96 [0.92-1],0.0706093751138354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,5,0.96 [0.92-1],0.0740472989784197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.96 [0.92-1],0.0741611243043166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,5,1.04 [1-1.09],0.0789310410032216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK8,Kallikrein-8,Inverse variance weighted,5,0.96 [0.93-1],0.0791099699237564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,5,1.05 [0.99-1.11],0.0815397549408903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADA2,Adenosine deaminase 2,Inverse variance weighted,5,1.05 [0.99-1.11],0.085981356664455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,5,0.97 [0.93-1.01],0.0886216442277747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,5,1.05 [0.99-1.11],0.0935703915187121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,5,0.95 [0.89-1.01],0.0944490008546892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,5,1.05 [0.99-1.11],0.0961789491307624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MB,Myoglobin,Inverse variance weighted,5,0.97 [0.93-1.01],0.0973452752163882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,5,0.97 [0.93-1.01],0.0976117972219204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,5,1.07 [0.99-1.16],0.0987873255847424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,5,1.07 [0.99-1.16],0.0993141210080277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,5,1.06 [0.99-1.14],0.101371010268034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,5,0.97 [0.93-1.01],0.1015357440489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,5,1.04 [0.99-1.08],0.103687156287534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,5,0.97 [0.93-1.01],0.105622266845911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD93,Complement component C1q receptor,Inverse variance weighted,5,0.96 [0.92-1.01],0.10572004953208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PLXNB2,Plexin-B2,Inverse variance weighted,5,1.07 [0.99-1.15],0.106304707043059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FBLN2,Fibulin-2,Inverse variance weighted,5,0.96 [0.91-1.01],0.106974180653044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,5,0.97 [0.93-1.01],0.109769870399064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.96 [0.9-1.01],0.110985591689009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DPT,Dermatopontin,Inverse variance weighted,5,0.96 [0.91-1.01],0.112680406849634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,5,0.97 [0.92-1.01],0.115628175772121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,5,1.03 [0.99-1.07],0.11637691041735,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MELTF,Melanotransferrin,Inverse variance weighted,5,1.05 [0.99-1.11],0.116732317092872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,5,0.97 [0.94-1.01],0.117107506304077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BOC,Brother of CDO,Inverse variance weighted,5,1.04 [0.99-1.08],0.118270654276405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,5,1.03 [0.99-1.08],0.119121529587935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP3,Stromelysin-1,Inverse variance weighted,5,1.03 [0.99-1.06],0.119947857664901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.95 [0.9-1.01],0.120971434457879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,APOA2,Apolipoprotein A-II,Inverse variance weighted,5,0.94 [0.88-1.02],0.121660210313389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,5,1.03 [0.99-1.08],0.121664470341658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CAPG,Macrophage-capping protein,Inverse variance weighted,5,0.97 [0.92-1.01],0.12735451572894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,5,1.05 [0.99-1.11],0.130592382429135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,5,0.95 [0.9-1.01],0.132360417323889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,5,1.03 [0.99-1.08],0.13534177719148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,5,0.97 [0.93-1.01],0.13581196318643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.96 [0.91-1.01],0.136130085998337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,5,0.97 [0.93-1.01],0.137903081019244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CYTL1,Cytokine-like protein 1,Inverse variance weighted,5,0.95 [0.9-1.02],0.139574516994485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,5,0.97 [0.92-1.01],0.143400710237199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSZ,Cathepsin Z,Inverse variance weighted,5,1.04 [0.99-1.11],0.143604919237148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,OGN,Mimecan,Inverse variance weighted,5,0.96 [0.91-1.01],0.146775370867593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSB,Cathepsin B,Inverse variance weighted,5,0.93 [0.85-1.03],0.149607508252945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,5,0.97 [0.93-1.01],0.150364692695483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,5,1.03 [0.99-1.07],0.153252522521493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NEFL,Neurofilament light polypeptide,Inverse variance weighted,5,1.03 [0.99-1.07],0.15518788550303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,5,0.97 [0.93-1.01],0.156160824038564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RTN4R,Reticulon-4 receptor,Inverse variance weighted,5,1.07 [0.98-1.16],0.156825581756103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,5,1.03 [0.99-1.08],0.157445085025623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DSG3,Desmoglein-3,Inverse variance weighted,5,0.97 [0.93-1.01],0.160604645716684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.97 [0.92-1.01],0.162431023317314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,5,1.04 [0.98-1.1],0.163411740864502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLMP,CXADR-like membrane protein,Inverse variance weighted,5,0.95 [0.87-1.02],0.168320342119354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.95 [0.89-1.02],0.172898971495769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,5,0.97 [0.92-1.02],0.178213993152599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,5,0.97 [0.93-1.01],0.179654175431082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,5,1.04 [0.98-1.09],0.179753702895557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RGMA,Repulsive guidance molecule A,Inverse variance weighted,5,1.03 [0.99-1.07],0.181549756221721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.04 [0.98-1.1],0.183089507344072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RETN,Resistin,Inverse variance weighted,5,0.97 [0.92-1.02],0.183472935074724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,5,1.03 [0.99-1.07],0.185862059356326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,5,1.04 [0.98-1.1],0.191360958578261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,5,0.97 [0.92-1.02],0.199877291029882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,5,0.94 [0.86-1.03],0.202204941705015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MDK,Midkine,Inverse variance weighted,5,1.03 [0.98-1.09],0.202832283748384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SDC1,Syndecan-1,Inverse variance weighted,5,1.03 [0.98-1.07],0.207212056921638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,5,0.96 [0.91-1.02],0.209598195013593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,5,0.97 [0.91-1.02],0.212218639417336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,5,0.98 [0.94-1.01],0.215635443059817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EDN1,Endothelin-1,Inverse variance weighted,5,0.96 [0.91-1.02],0.220938260292222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,5,0.98 [0.95-1.01],0.22537021198615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,5,0.96 [0.9-1.03],0.228240750533064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL17C,Interleukin-17C,Inverse variance weighted,5,1.03 [0.98-1.07],0.229077260349793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,5,0.97 [0.92-1.02],0.231946020141857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA4,Carbonic anhydrase 4,Inverse variance weighted,5,0.97 [0.93-1.02],0.241994851309727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,5,1.04 [0.97-1.11],0.244081907533037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AREG,Amphiregulin,Inverse variance weighted,5,1.04 [0.97-1.11],0.246529390225434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,5,1.05 [0.96-1.15],0.24676007306164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,5,1.03 [0.98-1.09],0.254211928891499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,5,1.03 [0.98-1.08],0.257731424260935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,REG1B,Lithostathine-1-beta,Inverse variance weighted,5,1.03 [0.98-1.07],0.25969385421465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFF1,Trefoil factor 1,Inverse variance weighted,5,1.03 [0.98-1.09],0.261035550141841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.03 [0.98-1.09],0.262409780302415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GCG,Pro-glucagon,Inverse variance weighted,5,1.06 [0.96-1.17],0.262538385844861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL14,C-C motif chemokine 14,Inverse variance weighted,5,0.98 [0.94-1.02],0.262584118330229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.97 [0.93-1.02],0.264008012891235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCN4,CCN family member 4,Inverse variance weighted,5,1.03 [0.98-1.08],0.267772120719337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LCN15,Lipocalin-15,Inverse variance weighted,5,1.02 [0.98-1.07],0.267952747842722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,5,0.96 [0.9-1.03],0.268212967039566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,5,1.04 [0.97-1.11],0.272180915576234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PENK,Proenkephalin-A,Inverse variance weighted,5,0.98 [0.94-1.02],0.274813556014246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,5,0.97 [0.93-1.02],0.275420494595454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CST3,Cystatin-C,Inverse variance weighted,5,0.98 [0.94-1.02],0.276264595201325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,5,0.96 [0.88-1.04],0.276934617907943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHGA,Chromogranin-A,Inverse variance weighted,5,0.98 [0.93-1.02],0.278127898199555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEPTIN8,Septin-8,Inverse variance weighted,5,0.96 [0.9-1.03],0.278677195240985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALCA,Calcitonin,Inverse variance weighted,5,0.96 [0.9-1.03],0.281299127427951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NECTIN4,Nectin-4,Inverse variance weighted,5,0.97 [0.93-1.02],0.281530036975526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,5,0.98 [0.94-1.02],0.281584733486171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,5,0.98 [0.93-1.02],0.281804257288537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP12,Macrophage metalloelastase,Inverse variance weighted,5,1.05 [0.96-1.14],0.286053260190214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DLK1,Protein delta homolog 1,Inverse variance weighted,5,1.06 [0.95-1.17],0.291055812386308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,5,1.03 [0.98-1.08],0.292286808098289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.98 [0.93-1.02],0.293685849184349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD99,CD99 antigen,Inverse variance weighted,5,0.98 [0.94-1.02],0.294117234709671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,5,0.97 [0.92-1.02],0.296540566669362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD160,CD160 antigen,Inverse variance weighted,5,0.98 [0.93-1.02],0.297554914509561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,5,1.02 [0.98-1.07],0.299066496848935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA12,Carbonic anhydrase 12,Inverse variance weighted,5,0.97 [0.93-1.02],0.302311491410534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,5,1.04 [0.97-1.11],0.303022092399193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,5,1.05 [0.96-1.14],0.304894629723249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MUC13,Mucin-13,Inverse variance weighted,5,1.03 [0.97-1.09],0.306515300215101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.96 [0.9-1.04],0.311257133750089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,5,0.98 [0.93-1.02],0.315513003376028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPRR3,Small proline-rich protein 3,Inverse variance weighted,5,0.98 [0.93-1.02],0.31756613101479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,5,0.96 [0.88-1.04],0.317990095294573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DSC2,Desmocollin-2,Inverse variance weighted,5,0.98 [0.94-1.02],0.319411129039443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCGB1A1,Uteroglobin,Inverse variance weighted,5,0.97 [0.92-1.03],0.320468291458412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,5,1.02 [0.98-1.07],0.320557851778656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ELN,Elastin,Inverse variance weighted,5,0.97 [0.92-1.03],0.329127454219418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,5,0.98 [0.94-1.02],0.339569642381898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,5,0.98 [0.93-1.03],0.342125393960309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KITLG,Kit ligand,Inverse variance weighted,5,0.98 [0.94-1.02],0.342299014028382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD48,CD48 antigen,Inverse variance weighted,5,0.98 [0.94-1.02],0.34517391982753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,5,1.03 [0.97-1.09],0.345353427075998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,5,1.02 [0.97-1.08],0.347157227394299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,5,0.98 [0.94-1.02],0.348208760330044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.98 [0.94-1.02],0.350218399523929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,5,0.98 [0.94-1.02],0.350233487968125,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD55,Complement decay-accelerating factor,Inverse variance weighted,5,0.98 [0.93-1.03],0.353908106725519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL23,C-C motif chemokine 23,Inverse variance weighted,5,0.96 [0.89-1.04],0.354520865834501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,5,1.04 [0.96-1.12],0.360702229402345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CKB,Creatine kinase B-type,Inverse variance weighted,5,0.93 [0.8-1.09],0.365081480767409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSO,Cathepsin O,Inverse variance weighted,5,1.04 [0.95-1.14],0.366095199833423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,5,0.98 [0.93-1.03],0.36781070165511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,5,1.04 [0.96-1.12],0.368457852319075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,5,1.03 [0.97-1.09],0.3719953757833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,5,0.98 [0.94-1.02],0.372758204456025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.95 [0.85-1.06],0.374261480962081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,STC1,Stanniocalcin-1,Inverse variance weighted,5,1.03 [0.97-1.09],0.37459092400253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RTBDN,Retbindin,Inverse variance weighted,5,0.97 [0.91-1.04],0.379282723204351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DTNB,Dystrobrevin beta,Inverse variance weighted,5,0.98 [0.94-1.02],0.379509315257074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,5,0.98 [0.93-1.03],0.379929761497741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,5,0.97 [0.91-1.04],0.382020698956495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1.03 [0.96-1.11],0.383199386288274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,5,0.97 [0.9-1.04],0.383837449131621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH3,Cadherin-3,Inverse variance weighted,5,0.98 [0.94-1.02],0.383899526722181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,5,0.98 [0.95-1.02],0.389243787568967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,5,1.03 [0.96-1.1],0.391082306564874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDH6,Cadherin-6,Inverse variance weighted,5,0.98 [0.93-1.03],0.39828850709636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,5,1.03 [0.97-1.09],0.404094598746075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,5,0.98 [0.94-1.03],0.406955439505813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,5,1.02 [0.98-1.06],0.409986715707461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALB2,Calretinin,Inverse variance weighted,5,1.03 [0.96-1.1],0.415317336911131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,5,1.02 [0.97-1.07],0.416169593698025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.03 [0.95-1.12],0.417947528963715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LMNB2,Lamin-B2,Inverse variance weighted,5,0.98 [0.94-1.03],0.418365873715824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD83,CD83 antigen,Inverse variance weighted,5,1.02 [0.97-1.08],0.421181837235993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,5,0.98 [0.94-1.03],0.421974579692779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RSPO1,R-spondin-1,Inverse variance weighted,5,0.97 [0.91-1.04],0.42641861010031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,5,0.98 [0.94-1.03],0.428733206574195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PI3,Elafin,Inverse variance weighted,5,0.98 [0.94-1.03],0.429433143989234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,5,0.98 [0.92-1.03],0.429522884194362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,5,1.02 [0.97-1.07],0.431636289372777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WNT9A,Protein Wnt-9a,Inverse variance weighted,5,0.98 [0.94-1.02],0.434644616284252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RGMB,RGM domain family member B,Inverse variance weighted,5,0.98 [0.94-1.03],0.435106734972078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,5,0.97 [0.91-1.04],0.441824082096523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,THBD,Thrombomodulin,Inverse variance weighted,5,1.02 [0.97-1.08],0.451291949649262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASET2,Ribonuclease T2,Inverse variance weighted,5,1.04 [0.94-1.15],0.451924311889356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,5,1.02 [0.97-1.07],0.452500018572292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,5,0.98 [0.95-1.02],0.453889369325484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1.03 [0.96-1.1],0.46068805462526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,5,0.98 [0.91-1.04],0.461565652426416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.97 [0.9-1.05],0.464801449024288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,5,1.02 [0.96-1.09],0.465200491808481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.02 [0.97-1.06],0.466076985101179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPARCL1,SPARC-like protein 1,Inverse variance weighted,5,0.99 [0.95-1.02],0.466293022711612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLC,Galectin-10,Inverse variance weighted,5,0.98 [0.94-1.03],0.469742847927343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,5,0.97 [0.9-1.05],0.475692604960689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DSG2,Desmoglein-2,Inverse variance weighted,5,0.97 [0.88-1.06],0.479100856749391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.02 [0.96-1.08],0.479576162639672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,5,1.01 [0.97-1.06],0.480112734168074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,5,0.98 [0.92-1.04],0.484745106503584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,5,1.03 [0.95-1.1],0.487324282214973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,5,0.95 [0.82-1.1],0.489788130884681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,5,0.98 [0.93-1.04],0.491235236940424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,5,1.01 [0.98-1.04],0.492921156065375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,5,0.98 [0.94-1.03],0.494440269901329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,5,1.01 [0.97-1.06],0.496903227813154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,5,1.02 [0.97-1.06],0.498017899082363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRSS8,Prostasin,Inverse variance weighted,5,1.03 [0.95-1.12],0.498310952146397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,0.98 [0.93-1.03],0.499844130763062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,1.03 [0.94-1.14],0.501335230665093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,5,0.98 [0.94-1.03],0.502752253011227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,5,0.98 [0.92-1.04],0.502856119720219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,5,1.02 [0.96-1.08],0.505252454148111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,5,0.98 [0.92-1.04],0.506457335624964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MATN2,Matrilin-2,Inverse variance weighted,5,1.01 [0.97-1.06],0.510458647979274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CSTB,Cystatin-B,Inverse variance weighted,5,1.01 [0.98-1.05],0.512602176404962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANGPT2,Angiopoietin-2,Inverse variance weighted,5,1.02 [0.96-1.08],0.515431457194477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,5,0.97 [0.89-1.06],0.51776361390215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.03 [0.95-1.11],0.51849712176077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,5,1.01 [0.97-1.06],0.518524806397441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPON1,Spondin-1,Inverse variance weighted,5,1.02 [0.96-1.08],0.519003190058005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PKD1,Polycystin-1,Inverse variance weighted,5,1.02 [0.97-1.07],0.519050636307452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,5,0.99 [0.95-1.03],0.522692538898738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,5,0.97 [0.89-1.06],0.523338304410939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGER,Advanced glycosylation end product-specific receptor,Inverse variance weighted,5,0.96 [0.86-1.08],0.523392058683983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,5,1.02 [0.96-1.07],0.531720096799571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD27,CD27 antigen,Inverse variance weighted,5,0.98 [0.93-1.04],0.531726167987997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRELP,Prolargin,Inverse variance weighted,5,0.98 [0.93-1.04],0.532161650901207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEZ6L,Seizure 6-like protein,Inverse variance weighted,5,1.02 [0.97-1.07],0.534456237467483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.99 [0.94-1.03],0.534696377084587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,5,1.01 [0.98-1.05],0.535755957196877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,B2M,Beta-2-microglobulin,Inverse variance weighted,5,1.03 [0.94-1.14],0.53703741199615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL19,Interleukin-19,Inverse variance weighted,5,0.99 [0.95-1.03],0.537255851922765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,5,0.99 [0.94-1.03],0.540799232292507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,5,0.99 [0.95-1.03],0.541315122748075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,5,0.98 [0.91-1.05],0.542175479910729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,5,0.98 [0.92-1.04],0.542911334381231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP7,Matrilysin,Inverse variance weighted,5,1.02 [0.95-1.11],0.543814538288235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,5,0.98 [0.94-1.04],0.544318954937079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGRP,Agouti-related protein,Inverse variance weighted,5,1.03 [0.94-1.13],0.54678749525635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,5,0.98 [0.93-1.04],0.547020197599237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AMBP,Protein AMBP,Inverse variance weighted,5,0.98 [0.91-1.05],0.547612890979892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.03 [0.94-1.12],0.54831828250432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,5,1.01 [0.97-1.06],0.54870976770716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.02 [0.96-1.09],0.553949258808317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD276,CD276 antigen,Inverse variance weighted,5,1.01 [0.97-1.05],0.556092095070441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,5,1.01 [0.97-1.06],0.560289547719799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,5,1.09 [0.82-1.44],0.562262315093214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA9,Carbonic anhydrase 9,Inverse variance weighted,5,1.01 [0.97-1.06],0.563804943744181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MMP10,Stromelysin-2,Inverse variance weighted,5,0.99 [0.95-1.03],0.566697408554362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,5,0.99 [0.94-1.03],0.568134023229072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,5,1.14 [0.73-1.78],0.568719720270119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAYN,Layilin,Inverse variance weighted,5,0.98 [0.91-1.05],0.568753096079318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,5,0.78 [0.34-1.82],0.570682377901282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,5,0.98 [0.89-1.06],0.572864478453666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,0.99 [0.95-1.03],0.57525721995193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,5,0.99 [0.95-1.03],0.578717709233104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,5,1.01 [0.97-1.05],0.580206244506632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PCDH7,Protocadherin-7,Inverse variance weighted,5,1.02 [0.95-1.1],0.58148141288987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,5,1.02 [0.96-1.08],0.581550093201331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NECTIN2,Nectin-2,Inverse variance weighted,5,1.01 [0.97-1.06],0.582218491539946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,5,0.99 [0.95-1.03],0.58323394806244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,5,0.99 [0.94-1.04],0.584283009460962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SNCG,Gamma-synuclein,Inverse variance weighted,5,1.01 [0.97-1.06],0.586118152452031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,5,1.02 [0.96-1.08],0.586515705746575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RSPO3,R-spondin-3,Inverse variance weighted,5,0.99 [0.95-1.03],0.587016102516326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCG3,Secretogranin-3,Inverse variance weighted,5,0.99 [0.95-1.03],0.587673992211992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PREB,Prolactin regulatory element-binding protein,Inverse variance weighted,5,1.01 [0.97-1.06],0.590022040096831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,5,0.99 [0.95-1.03],0.591897187225369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DRAXIN,Draxin,Inverse variance weighted,5,0.99 [0.95-1.03],0.593883843015084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,5,0.98 [0.93-1.04],0.594774426537384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,5,0.97 [0.86-1.09],0.596422203724407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,5,0.98 [0.9-1.06],0.601182410361282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,XG,Glycoprotein Xg,Inverse variance weighted,5,0.99 [0.94-1.04],0.602164209964774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,5,0.98 [0.91-1.05],0.602176519440525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,5,1.02 [0.94-1.12],0.603617876023104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ALCAM,CD166 antigen,Inverse variance weighted,5,1.01 [0.97-1.05],0.606163265435294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,5,1.02 [0.94-1.11],0.606927735586383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRG2,Bone marrow proteoglycan,Inverse variance weighted,5,0.98 [0.91-1.06],0.607793753555237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,5,0.99 [0.95-1.03],0.609838082958772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,5,1.02 [0.96-1.08],0.610485609719451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DLL1,Delta-like protein 1,Inverse variance weighted,5,1.01 [0.97-1.06],0.612846071179939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE6,Ribonuclease K6,Inverse variance weighted,5,0.99 [0.94-1.04],0.615893618086249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ITGB6,Integrin beta-6,Inverse variance weighted,5,1.02 [0.94-1.1],0.620609989224804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPY,Pro-neuropeptide Y,Inverse variance weighted,5,1.03 [0.9-1.18],0.62091100798196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.02 [0.95-1.09],0.627338560961764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RNASE4,Ribonuclease 4,Inverse variance weighted,5,0.99 [0.93-1.05],0.631128830456154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,5,1.03 [0.92-1.14],0.631832443091938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,5,1.01 [0.97-1.06],0.634653833820468,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,5,0.99 [0.96-1.03],0.635984823986924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,5,1.01 [0.95-1.08],0.638129445341532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,5,1.01 [0.96-1.07],0.639320248992286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,5,1.01 [0.97-1.05],0.641159051763902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,5,0.98 [0.92-1.06],0.6438540867522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,5,0.97 [0.87-1.09],0.645307722268363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.03 [0.91-1.17],0.64533665382612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,5,0.98 [0.91-1.06],0.647654731408702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,5,0.98 [0.9-1.07],0.64844793825345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.02 [0.95-1.09],0.650833217237173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CDSN,Corneodesmosin,Inverse variance weighted,5,1.06 [0.83-1.36],0.652242467351422,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,5,1.02 [0.94-1.1],0.653200483974335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,5,0.98 [0.91-1.06],0.654437105400886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DPY30,Protein dpy-30 homolog,Inverse variance weighted,5,0.99 [0.92-1.05],0.656001336637275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTSL,Cathepsin L1,Inverse variance weighted,5,1.01 [0.97-1.05],0.658538016244098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,5,0.98 [0.92-1.05],0.660351018115104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEMA3F,Semaphorin-3F,Inverse variance weighted,5,1.01 [0.95-1.08],0.661114117183116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,5,1.02 [0.94-1.1],0.662233769114497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,5,0.99 [0.92-1.05],0.663131796246457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,5,1.02 [0.93-1.12],0.664839518092285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCN5,CCN family member 5,Inverse variance weighted,5,0.99 [0.92-1.05],0.667151394789866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.99 [0.95-1.03],0.669928379175775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,5,0.99 [0.94-1.04],0.682192796045514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK10,Kallikrein-10,Inverse variance weighted,5,1.02 [0.94-1.1],0.683147065759408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,5,0.99 [0.95-1.04],0.683579717515655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PI16,Peptidase inhibitor 16,Inverse variance weighted,5,0.99 [0.93-1.05],0.686366793010742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,5,0.99 [0.96-1.03],0.687681247783071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NXPH3,Neurexophilin-3,Inverse variance weighted,5,0.99 [0.95-1.04],0.688097312217306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DKK4,Dickkopf-related protein 4,Inverse variance weighted,5,1.01 [0.96-1.06],0.69243331742168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,5,1.01 [0.95-1.08],0.692670652096691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD7,T-cell antigen CD7,Inverse variance weighted,5,1.01 [0.97-1.05],0.693724807110371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,5,0.99 [0.95-1.04],0.698474748852235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCG2,Secretogranin-2,Inverse variance weighted,5,1.01 [0.95-1.09],0.699023902959544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,OCLN,Occludin,Inverse variance weighted,5,1.02 [0.93-1.12],0.699384463335528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,5,0.99 [0.94-1.04],0.700903870472911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,5,1.01 [0.96-1.05],0.700974318134817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,5,1.01 [0.97-1.05],0.701027413144638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,5,1.02 [0.94-1.1],0.70349364119667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHGB,Secretogranin-1,Inverse variance weighted,5,0.99 [0.95-1.03],0.704195843409313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,5,0.99 [0.92-1.06],0.705298034028472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,5,1.01 [0.96-1.07],0.709414112328609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL16,Pro-interleukin-16,Inverse variance weighted,5,0.99 [0.91-1.07],0.711015627890595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,5,1.01 [0.96-1.07],0.713771556811826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,UMOD,Uromodulin,Inverse variance weighted,5,1.01 [0.95-1.08],0.713941888483446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,AGRN,Agrin,Inverse variance weighted,5,1.02 [0.92-1.12],0.718962583761693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,5,0.99 [0.96-1.03],0.720154565412445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.99 [0.93-1.05],0.728255589459249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,5,1.01 [0.96-1.06],0.730587541806811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,5,1.01 [0.94-1.09],0.730622054434464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,5,1.01 [0.97-1.05],0.735052177339485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FGF5,Fibroblast growth factor 5,Inverse variance weighted,5,0.99 [0.96-1.03],0.737217449121949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ABCA2,ATP-binding cassette sub-family A member 2,Inverse variance weighted,5,1.01 [0.95-1.08],0.737532709728284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,5,0.99 [0.95-1.04],0.73771614425275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,5,1.01 [0.95-1.08],0.738272164814125,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,5,0.99 [0.94-1.04],0.738799575708443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,5,0.99 [0.94-1.04],0.739578081549361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,5,1.01 [0.95-1.08],0.739766576874193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VASN,Vasorin,Inverse variance weighted,5,1.01 [0.95-1.08],0.743130748957688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL15,C-C motif chemokine 15,Inverse variance weighted,5,1.01 [0.96-1.06],0.743670806722506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,5,1.01 [0.97-1.05],0.749285918943109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD46,Membrane cofactor protein,Inverse variance weighted,5,1.01 [0.96-1.05],0.749796432170183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,5,1.01 [0.95-1.07],0.755245004882031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK4,Kallikrein-4,Inverse variance weighted,5,0.99 [0.94-1.05],0.755475609615523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,5,0.99 [0.91-1.08],0.75603024931899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAM3D,Protein FAM3D,Inverse variance weighted,5,1.01 [0.97-1.04],0.756754582032915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFNA4,Ephrin-A4,Inverse variance weighted,5,1.01 [0.95-1.07],0.757673464376638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.01 [0.95-1.07],0.757785328505315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,5,0.99 [0.95-1.04],0.760120555661576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,5,1.01 [0.95-1.07],0.762639152943733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,5,0.99 [0.93-1.06],0.764847488786843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,1.01 [0.95-1.07],0.76545007398589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,5,1.02 [0.91-1.14],0.765948100827006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,5,1.01 [0.96-1.06],0.766820184708935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NRP1,Neuropilin-1,Inverse variance weighted,5,0.99 [0.93-1.05],0.768344106291149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VGF,Neurosecretory protein VGF,Inverse variance weighted,5,0.99 [0.91-1.07],0.771596498641231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,POF1B,Protein POF1B,Inverse variance weighted,5,1.01 [0.94-1.08],0.772127299440695,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,5,1.01 [0.96-1.06],0.772725953474297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DKK3,Dickkopf-related protein 3,Inverse variance weighted,5,1.01 [0.97-1.05],0.775535781589094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,5,0.99 [0.9-1.09],0.777486861216809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,5,0.99 [0.94-1.05],0.78345273673277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,5,1.01 [0.96-1.06],0.784512224787972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,5,1.01 [0.96-1.05],0.78477711091729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.01 [0.93-1.1],0.786602062327551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,5,0.99 [0.95-1.04],0.786657245442878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.99 [0.92-1.06],0.786881259664655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.99 [0.94-1.05],0.787242871178754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD302,CD302 antigen,Inverse variance weighted,5,1.02 [0.89-1.17],0.787647002750789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VWC2,Brorin,Inverse variance weighted,5,0.99 [0.94-1.05],0.788222702505006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,5,0.99 [0.92-1.07],0.790245483520093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,5,0.99 [0.94-1.05],0.791428357952391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DDR1,Epithelial discoidin domain-containing receptor 1,Inverse variance weighted,5,1.01 [0.92-1.11],0.791934968284318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS3,Galectin-3,Inverse variance weighted,5,1.01 [0.94-1.09],0.792222586613115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,5,1.01 [0.95-1.07],0.795960166676386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,5,1.01 [0.96-1.06],0.796375374693666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,5,1.01 [0.96-1.05],0.797178294811729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,5,1.01 [0.95-1.06],0.798030238856696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,5,0.99 [0.94-1.05],0.798815651995182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,5,0.99 [0.95-1.04],0.799698612401068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,5,0.99 [0.95-1.04],0.799878049783305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ANG,Angiogenin,Inverse variance weighted,5,1.01 [0.95-1.07],0.801994811656479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,5,1.01 [0.96-1.05],0.803493103210591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,5,1.01 [0.93-1.11],0.804165179782438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,5,1 [0.97-1.04],0.80452923368785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,5,0.99 [0.94-1.05],0.807138025486031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PCDH1,Protocadherin-1,Inverse variance weighted,5,0.99 [0.95-1.04],0.807170777002629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,5,1.01 [0.93-1.1],0.808936420850274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,5,0.99 [0.95-1.04],0.812161062564675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PRSS27,Serine protease 27,Inverse variance weighted,5,1 [0.97-1.05],0.812488029359994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCL16,C-C motif chemokine 16,Inverse variance weighted,5,1.01 [0.93-1.1],0.814309027510393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,5,1.01 [0.94-1.09],0.814526242475712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,5,1.01 [0.94-1.08],0.819111026712841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,5,1.01 [0.93-1.09],0.819824010776238,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EFNA1,Ephrin-A1,Inverse variance weighted,5,0.99 [0.95-1.04],0.820346723648107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CA14,Carbonic anhydrase 14,Inverse variance weighted,5,1 [0.95-1.04],0.821815838059038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,5,1.01 [0.96-1.06],0.822163599635964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,INHBB,Inhibin beta B chain,Inverse variance weighted,5,1.01 [0.96-1.06],0.823484401498729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,5,1.01 [0.96-1.05],0.823830505194859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS9,Galectin-9,Inverse variance weighted,5,1.01 [0.94-1.08],0.827486225462737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,5,0.99 [0.92-1.07],0.828049623185199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SPON2,Spondin-2,Inverse variance weighted,5,1 [0.96-1.05],0.829135180301508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK6,Kallikrein-6,Inverse variance weighted,5,0.99 [0.94-1.05],0.829952789141649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,XCL1,Lymphotactin,Inverse variance weighted,5,1.01 [0.96-1.06],0.830120276413516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,5,1 [0.96-1.05],0.834200496541374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,5,1 [0.96-1.05],0.834702230862659,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,5,0.99 [0.93-1.06],0.835697980703931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,5,1 [0.96-1.05],0.838433294591751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,5,0.99 [0.92-1.07],0.841027642203577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,5,1.01 [0.94-1.07],0.842274494120516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,5,1 [0.96-1.05],0.845130390146273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,5,1 [0.95-1.04],0.850761061889243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1 [0.96-1.05],0.851787917154265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLK14,Kallikrein-14,Inverse variance weighted,5,1.01 [0.94-1.08],0.856247706823497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,5,1 [0.95-1.04],0.856780270716411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ULBP2,UL16-binding protein 2,Inverse variance weighted,5,1.01 [0.95-1.07],0.863515648760364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,5,1 [0.95-1.05],0.871994632060885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CX3CL1,Fractalkine,Inverse variance weighted,5,0.99 [0.9-1.09],0.873435770869909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GUCA2A,Guanylin,Inverse variance weighted,5,1 [0.94-1.05],0.873779687193472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,DCN,Decorin,Inverse variance weighted,5,1 [0.95-1.06],0.874527095315436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TCN2,Transcobalamin-2,Inverse variance weighted,5,1 [0.95-1.06],0.878862892732775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,5,1 [0.95-1.05],0.882731646035291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.01 [0.91-1.11],0.883940198976274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,5,1 [0.96-1.05],0.885998518240761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,F3,Tissue factor,Inverse variance weighted,5,1 [0.95-1.04],0.886882080965058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PGF,Placenta growth factor,Inverse variance weighted,5,1 [0.94-1.07],0.887657059828837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PSAP,Prosaposin,Inverse variance weighted,5,1 [0.95-1.06],0.890955987537402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,5,1.01 [0.91-1.11],0.89172937888032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,5,1 [0.95-1.05],0.893228702020413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Inverse variance weighted,5,1 [0.94-1.08],0.893519246562719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,5,1 [0.95-1.04],0.895501922332897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,BSG,Basigin,Inverse variance weighted,5,1 [0.94-1.05],0.898651244236491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,5,0.99 [0.91-1.08],0.901559380030518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,5,1 [0.95-1.06],0.904634274285203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GPC1,Glypican-1,Inverse variance weighted,5,1 [0.96-1.04],0.911715473801583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NEO1,Neogenin,Inverse variance weighted,5,1 [0.95-1.06],0.916030393639179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1 [0.95-1.04],0.917203814599368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,5,1 [0.96-1.05],0.919121984345326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,5,1 [0.95-1.05],0.919239628519002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAM3B,Protein FAM3B,Inverse variance weighted,5,1 [0.94-1.07],0.919422919255471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,5,1 [0.96-1.05],0.920210085319849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CCN3,CCN family member 3,Inverse variance weighted,5,1 [0.93-1.07],0.923672998959286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD164,Sialomucin core protein 24,Inverse variance weighted,5,1 [0.95-1.06],0.926410349497108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1 [0.92-1.07],0.927819147577986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EGFLAM,Pikachurin,Inverse variance weighted,5,1 [0.92-1.1],0.929616417797723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,GRN,Progranulin,Inverse variance weighted,5,1 [0.95-1.06],0.933597880971772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PPL,Periplakin,Inverse variance weighted,5,1 [0.94-1.06],0.933866098080359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,LGALS1,Galectin-1,Inverse variance weighted,5,1 [0.95-1.05],0.940537788957951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FAM3C,Protein FAM3C,Inverse variance weighted,5,1 [0.96-1.04],0.940662759119704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NUCB2,Nucleobindin-2,Inverse variance weighted,5,1 [0.91-1.09],0.941811440809045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1 [0.95-1.06],0.942648529406092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,5,1 [0.93-1.07],0.942963562175182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,5,1 [0.9-1.1],0.945081011174746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FOLR2,Folate receptor beta,Inverse variance weighted,5,1 [0.93-1.08],0.947442813697343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,NPPC,C-type natriuretic peptide,Inverse variance weighted,5,1 [0.93-1.07],0.947870199303482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ADM,Pro-adrenomedullin,Inverse variance weighted,5,1 [0.95-1.06],0.950766225998254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,5,1 [0.94-1.06],0.95672061881055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,FABP6,Gastrotropin,Inverse variance weighted,5,1 [0.94-1.06],0.958272497179154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,PALM2,Paralemmin-2,Inverse variance weighted,5,1 [0.96-1.04],0.964080459292862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1 [0.9-1.1],0.970756544753152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,5,1 [0.9-1.12],0.972816866787314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,ENAH,Protein enabled homolog,Inverse variance weighted,5,1 [0.96-1.05],0.97706876487604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,MOG,Myelin-oligodendrocyte glycoprotein,Inverse variance weighted,5,1 [0.93-1.07],0.978849791715656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CALB1,Calbindin,Inverse variance weighted,5,1 [0.94-1.07],0.988068363588209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,5,1 [0.94-1.07],0.988285489848424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,5,1 [0.94-1.07],0.989913052148207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,5,1 [0.95-1.06],0.992385249434569,trans
